Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis

被引:12
|
作者
Alosaimi, Fahad D. [1 ]
AlMulhem, Alaa [2 ]
AlShalan, Hanan [2 ]
Alqazlan, Mohammad [3 ]
Aldaif, Abdulgader [4 ]
Kowgier, Matthew [5 ]
Balasundaram, Janooshsheya [6 ]
Sockalingam, Sanjeev [6 ,7 ]
机构
[1] King Saud Univ, Dept Psychiat, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Med, Riyadh, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Med Hlth, Riyadh, Saudi Arabia
[4] King Saud Univ, Dept Neurol, Riyadh, Saudi Arabia
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[6] Univ Hlth Network, Ctr Mental Hlth, Toronto, ON, Canada
[7] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
来源
关键词
multiple sclerosis; adherence; depression; attachment style; culture; MORTALITY; SEVERITY; DEPRESSION; PREVALENCE; VALIDITY; CARE; TOOL;
D O I
10.2147/PPA.S129678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Our aim was to identify the impact of psychosocial predictors, specifically relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culturespecific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients. Methods: In this cross-sectional observational study, patients from two MS clinics in Saudi Arabia completed self-reported questionnaires focused on MS treatment adherence, physical symptom burden, relationship style, cultural beliefs, depressive symptoms, anxiety, and cognitive impairment. Results: A total of 163 MS patients participated, 81.6% of them were female, and the mean age of the patients was 31.6 years. Mean patient-reported adherence to their MS treatment regimen was 79.47%+/- 25.26%. Multivariate linear regression analysis only identified patients' belief that their MS was due to "supernatural" forces as being significantly negatively associated with MS medication adherence. Conclusion: This study demonstrates the importance of cultural interpretations to MS medication adherence in comparison to psychosocial factors. Education and family involvement in the treatment planning may address this issue and warrant further research.
引用
收藏
页码:513 / 518
页数:6
相关论文
共 50 条
  • [21] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Jai Perumal
    Omar Khan
    Current Treatment Options in Neurology, 2012, 14 : 256 - 263
  • [22] Defining non-adherence to the injectable disease-modifying therapies in multiple sclerosis
    McKay, K. A.
    Tremlett, H.
    Patten, S. B.
    Fisk, J. D.
    Evans, C.
    Fiest, K.
    Campbell, T.
    Marrie, R. A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 339 - 340
  • [23] 'Let's stick together' Adherence to disease-modifying therapies in multiple sclerosis
    Berger, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (01) : 1 - 2
  • [24] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
    Langer-Gould, Annette M.
    Smith, Jessica B.
    Gonzales, Edlin G.
    Piehl, Fredrik
    Li, Bonnie H.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [25] Oral Disease-Modifying Therapies for Multiple Sclerosis
    Kim, Woojun
    Zandona, Manuella Edler
    Kim, Su-Hyun
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 9 - 19
  • [26] Using disease-modifying therapies for multiple sclerosis
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 48 (03) : 314 - 314
  • [27] Current disease-modifying therapies in multiple sclerosis
    Kieseier, BC
    Hartung, HP
    SEMINARS IN NEUROLOGY, 2003, 23 (02) : 133 - 145
  • [28] Impact of adherence to disease-modifying therapies on employment among veterans with multiple sclerosis
    Rabadi, Meheroz H.
    Just, Kimberly
    Xu, Chao
    DISABILITY AND REHABILITATION, 2022, 44 (16) : 4415 - 4420
  • [29] Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
    Francesca Washington
    Dawn Langdon
    Journal of Neurology, 2022, 269 : 1861 - 1872
  • [30] Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist
    Banks, Aimee M.
    Peter, Megan E.
    Holder, Genna M.
    Jolly, Jacob A.
    Markley, Brandon M.
    Zuckerman, Scott L.
    Choi, Leena
    Nwosu, Sam
    Zuckerman, Autumn D.
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (05) : 605 - 611